venus williams glp 1 SerenaWilliams is opening up about her experience with the GLP-1 drug Zepbound. The recent public discourse around Williams's body—online commenters have noticed a change in her physique and demanded to know how Serena Williams feels 'light physically

Proceedings of the National Academy of Sciences , 84(10), 34343438

They do not provide cooling on their own but protect against the physical damage that is equally dangerous to peptide integrity

A recent retrospective cohort study looked at GLP-1 adherence in patients with obesity and with/without diabetes: Those with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Those without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two So yes access is a problem

You receive a structured approach that may include health evaluation, goal setting, nutrition guidance, progress tracking, medication education, and ongoing support

That falls short of tirzepatide numbers but represents a significant health improvement for many people and may be the appropriate starting point before considering pharmaceutical options